Food and Drug Administration (FDA)

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Food and Drug Administration (FDA)

BelVita Recall Exposes Serious Weakness in US Allergen Labeling

FDA Delays Approval of neffy™ Intranasal Epinephrine Until September

Viatris, Seller of EpiPen®, Petitions FDA to Delay Approval of neffy™...

Aravax Doses First Patient in Phase 2 Peanut Allergy Clinical Trial

FDA Issues New Draft Guidance Regarding Allergen Labeling and Cross-Contact

FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray

Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...

DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch

Hoping Needle-Free Intranasal Epinephrine will be Approved? Tell the FDA!

FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors

Your School On Our Map

FDA Accepts neffy® Filing for Child Dose, Sets March 6 for Decision